Nanotechnology has been extensively studied and exploited for cancer treatment as
nanoparticles can play a significant role as a drug delivery system. Compared to …

Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

Conventional chemotherapy, one of the most widely used cancer treatment methods, has
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …

It is anticipated that by 2030 approximately 13 million people will die of cancer. Common
cancer therapy often fails due to the development of multidrug resistance (MDR), resulting in …

Advanced cancer is still considered an incurable disease because of its metastatic spread to
distal organs and progressive gain of chemoresistance. Even though considerable treatment …

Nanomedicine, the application of nanotechnology to medicine, enabled the development of
nanoparticle therapeutic carriers. These drug carriers are passively targeted to tumors …

Cancer remains a major killer of mankind. Failure of conventional chemotherapy has
resulted in recurrence and development of virulent multi drug resistant (MDR) phenotypes …

Cancer nanotherapeutics are swiftly progressing and are being applied to solve several
limitations of conventional drug delivery systems such as non-specific biodistribution and …

Tumor cells develop resistance to chemotherapeutic drugs through multiple mechanisms.
Overexpression of efflux transporters is an important source of drug resistance. Efflux …

Nanotechnology has been the latest approach for diagnosis and treatment for cancer, which
opens up a new alternative therapeutic drug delivery option to treat disease. Nanoparticles …